RxDoctor Payments Data

Timothy Dailey, MD

Family Medicine · Boone, NCNPI 1164432399

Payments from drug & device makers

$1,144in general payments, 2019–2025

Across 70 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$511
  • Gilead$136
  • Novo Nordisk$86
  • Boehringer Ingelheim$70
  • Eisai Inc.$49
  • AstraZeneca$48
  • plus $244 from 10 others

What the payments were for

  • Speaking & faculty fees$151%
  • Food & beverage$1,12899%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,144 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$78,197
Medicare patients
138
Services billed
1,018

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$68,452
MounjaroTirzepatide49$62,021
TrulicityDulaglutide36$45,262
JardianceEmpagliflozin58$42,239
OzempicSemaglutide12$21,961
XareltoRivaroxaban14$14,191
Repatha SureclickEvolocumab13$9,212
Victoza 3-PakLiraglutide11$7,939
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,767
SynthroidLevothyroxine Sodium49$5,602
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,460
Colestipol Hcl35$3,434
Telmisartan73$3,151
Candesartan Cilexetil42$2,993
Estradiol25$2,638

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$511$107,28385 claims
PfizerEliquis$19$68,45264 claims
Boehringer IngelheimJardiance, Stiolto Respimat$70$47,69970 claims
Novo NordiskOzempic$86$21,96112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Boone

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →